Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (34)
Juha Jyrkäs, Toni Lassila & Ari Tolonen. (2023) Extrahepatic in vitro metabolism of peptides; comparison of human kidney and intestinal S9 fraction, human plasma and proximal tubule cells, using cyclosporine A, leuprorelin, and cetrorelix as model compounds. Journal of Pharmaceutical and Biomedical Analysis 225, pages 115219.
Crossref
Crossref
Katrina R. Viviano. (2022) Glucocorticoids, Cyclosporine, Azathioprine, Chlorambucil, and Mycophenolate in Dogs and Cats. Veterinary Clinics of North America: Small Animal Practice 52:3, pages 797-817.
Crossref
Crossref
Vincent Bruet, Marion Mosca, Amaury Briand, Patrick Bourdeau, Didier Pin, Noëlle Cochet-Faivre & Marie-Christine Cadiergues. (2022) Clinical Guidelines for the Use of Antipruritic Drugs in the Control of the Most Frequent Pruritic Skin Diseases in Dogs. Veterinary Sciences 9:4, pages 149.
Crossref
Crossref
Katrina R. Viviano. 2019. Pharmacotherapeutics for Veterinary Dispensing. Pharmacotherapeutics for Veterinary Dispensing
339
360
.
Yuki HOSHINO, Takanori INDEN, Riko OTAKA, Daisuke FUKUI, Hiroshi SATOH & Masaaki KATAYAMA. (2019) Interaction of cyclosporine with phenobarbital in cats: a preliminary study. Journal of Veterinary Medical Science 81:11, pages 1621-1623.
Crossref
Crossref
Kenneth E. PierceJr.Jr., David A. Wilkie, Anne J. Gemensky-Metzler, Paul G. Curran, Wendy M. Townsend, Simon M. Petersen-Jones & Joshua T. Bartoe. (2016) An association between systemic cyclosporine administration and development of acute bullous keratopathy in cats. Veterinary Ophthalmology 19, pages 77-85.
Crossref
Crossref
E. S. Roberts, K. A. VanLare, G. Strehlau, M. Peyrou, L. M. Roycroft & S. King. (2013)
Safety, tolerability, and pharmacokinetics of 6‐month daily dosing of an oral formulation of cyclosporine (
ATOPICA
for cats
®
) in cats
. Journal of Veterinary Pharmacology and Therapeutics 37:2, pages 161-168.
Crossref
Crossref
Peter Forsythe & Sue Paterson. (2014) Ciclosporin 10 years on: indications and efficacy. Veterinary Record 174:S2, pages 13-21.
Crossref
Crossref
Yutaka MIYA, Mai GODA, Hideo AKIYOSHI & Fumihito OHASHI. (2014) Constant Rate Infusion of Cyclosporine for Inflammatory Bowel Disease in a dogシクロスポリンの持続点滴を行った炎症性腸疾患の犬の1例. Journal of the Japan Veterinary Medical Association 67:8, pages 608-611.
Crossref
Crossref
Masaaki KATAYAMA, Yoshiki KAWAKAMI, Rieko KATAYAMA, Shunsuke SHIMAMURA, Yasuhiko OKAMURA & Yuji UZUKA. (2014) Preliminary Study of Effects of Multiple Oral Dosing of Clarithromycin on the Pharmacokinetics of Cyclosporine in Dogs. Journal of Veterinary Medical Science 76:3, pages 431-433.
Crossref
Crossref
T.M. Archer, D.M. Boothe, V.C. Langston, C.L. Fellman, K.V. Lunsford & A.J. Mackin. (2014) Oral Cyclosporine Treatment in Dogs: A Review of the Literature. Journal of Veterinary Internal Medicine 28:1, pages 1-20.
Crossref
Crossref
Katrina R. Viviano. (2013) Update on Immununosuppressive Therapies for Dogs and Cats. Veterinary Clinics of North America: Small Animal Practice 43:5, pages 1149-1170.
Crossref
Crossref
F. I. Al-Jenoobi, S. A. Al-Suwayeh, Iqbal Muzaffar, Mohd Aftab Alam, Khalid M. Al-Kharfy, Hesham M. Korashy, Abdullah M. Al-Mohizea, Abdul Ahad & Mohd Raish. (2013)
Effects of
Nigella sativa
and
Lepidium sativum
on Cyclosporine Pharmacokinetics
. BioMed Research International 2013, pages 1-6.
Crossref
Crossref
Brian S. Palmeiro. (2013) Cyclosporine in Veterinary Dermatology. Veterinary Clinics of North America: Small Animal Practice 43:1, pages 153-171.
Crossref
Crossref
Marcel Kovalik, Keith L. Thoday & Adri H.M. van den Broek. (2012) The use of ciclosporin A in veterinary dermatology. The Veterinary Journal 193:2, pages 317-325.
Crossref
Crossref
Masaaki Katayama, Noriko Nishijima, Yasuhiko Okamura, Rieko Katayama, Testuro Yamashita, Hiroaki Kamishina & Yuji Uzuka. (2012) Interaction of clarithromycin with cyclosporine in cats: pharmacokinetic study and case report. Journal of Feline Medicine and Surgery 14:4, pages 257-261.
Crossref
Crossref
Noel E. Radwanski, Rosario Cerundolo, Frances S. Shofer, Michael J. Hanley & Michael H. Court. (2011) Effects of powdered whole grapefruit and metoclopramide on the pharmacokinetics of cyclosporine in dogs. American Journal of Veterinary Research 72:5, pages 687-693.
Crossref
Crossref
Masaaki Katayama, Rieko Katayama & Hiroaki Kamishina. (2010) Effects of multiple oral dosing of itraconazole on the pharmacokinetics of cyclosporine in cats. Journal of Feline Medicine and Surgery 12:6, pages 512-514.
Crossref
Crossref
M. J. HANLEY, R. CERUNDOLO, N. RADWANSKI & M. H. COURT. (2010) Grapefruit juice, lyophilized grapefruit juice, and powdered whole grapefruit inhibit cytochrome P450-mediated triazolam hydroxylation by beagle dog liver microsomes. Journal of Veterinary Pharmacology and Therapeutics 33:2, pages 189-195.
Crossref
Crossref
Hiroki Konishi, Masaki Sumi, Tokuzo Minouchi, Akira Yamaji, Masaki Sumi, Nobuhito Shibata & Kanji Takada. (2004) Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats. Journal of Pharmacy and Pharmacology 56:4, pages 477-483.
Crossref
Crossref
D. J. LOEFFELBEIN, M. NIEBERLER, L. STEINSTRAESSER, R. BOECKMANN, F. HOELZLE, K.-D. WOLFF & M. R. KESTING. (2010) Effects of ciclosporin therapy on xylazineâ/âketamine anaesthesia in a rat model. Journal of Veterinary Pharmacology and Therapeutics 33:1, pages 100-102.
Crossref
Crossref
P. M. Krimer, S. B. Harvey, U. Blas-Machado, J. D. Lauderdale & P. A. Moore. (2009) Reversible Fibroadenomatous Mammary Hyperplasia in Male and Female New Zealand White Rabbits Associated with Cyclosporine A Administration. Veterinary Pathology 46:6, pages 1144-1148.
Crossref
Crossref
Brendan T. Griffin & Caitriona M. O’Driscoll. (2007) An Examination of the Effect of Intestinal First Pass Extraction on Intestinal Lymphatic Transport of Saquinavir in the Rat. Pharmaceutical Research 25:5, pages 1125-1133.
Crossref
Crossref
Frieder Kees, Michael Bucher, Frank Schweda, Harald Gschaidmeier, Juergen Burhenne, Gerd Mikus & Lothar Faerber. (2006) Comparative Bioavailability of the Microemulsion Formulation of Cyclosporine (Neoral) With a Generic Dispersion Formulation (Cicloral) in Young Healthy Male Volunteers. Therapeutic Drug Monitoring 28:3, pages 312-320.
Crossref
Crossref
Narine Baririan, Jean-Pierre Desager, Martine Petit & Yves Horsmans. (2006) CYP3A4 activity in four different animal species liver microsomes using 7-benzyloxyquinoline and HPLC/spectrofluorometric determination. Journal of Pharmaceutical and Biomedical Analysis 40:1, pages 211-214.
Crossref
Crossref
Stephanie R. Bruner. (2006) Updates in Therapeutics for Veterinary Dermatology. Veterinary Clinics of North America: Small Animal Practice 36:1, pages 39-58.
Crossref
Crossref
. 2005. Drug Metabolism. Drug Metabolism
243
268
.
J. Steffan, G. Strehlau, M. Maurer & A. Rohlfs. (2004) Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs. Journal of Veterinary Pharmacology and Therapeutics 27:4, pages 231-238.
Crossref
Crossref
Patrick J. Sinko, Jeevan R. Kunta, Helen H. Usansky & Barbara A. Perry. (2004) Differentiation of Gut and Hepatic First Pass Metabolism and Secretion of Saquinavir in Ported Rabbits. Journal of Pharmacology and Experimental Therapeutics 310:1, pages 359-366.
Crossref
Crossref
Sule Kalkan, Mukaddes Gumustekin, Oguz Aygoren, Yesim Tuncok, Ayse Gelal & Hulya Guven. (2004) The interaction of the diltiazem with oral and intravenous cyclosporine in rats. European Journal of Drug Metabolism and Pharmacokinetics 29:2, pages 119-123.
Crossref
Crossref
Eric Guaguere, Jean Steffan & Thierry Olivry. (2004) Cyclosporin A: a new drug in the field of canine dermatology. Veterinary Dermatology 15:2, pages 61-74.
Crossref
Crossref
D. Robson. (2003) Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats. Veterinary Record 152:24, pages 739-748.
Crossref
Crossref
Susan Wong, Harrison T. Wong & Vincent J. Wacher. (2002)
Minimal effect of ketoconazole on cyclosporine (SangCyA
TM
) oral absorption and first‐pass metabolism in rats: evidence of a significant vehicle effect on SangCyA absorption
. Biopharmaceutics & Drug Disposition 23:2, pages 53-57.
Crossref
Crossref
Vincent J. Wacher, Susan Wong & Harrison T. Wong. (2002) Peppermint Oil Enhances Cyclosporine Oral Bioavailability in Rats: Comparison with d‐α‐Tocopheryl Poly(ethylene glycol 1000) Succinate (TPGS) and Ketoconazole. Journal of Pharmaceutical Sciences 91:1, pages 77-90.
Crossref
Crossref